These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 7768151

  • 1. Bactericidal permeability-increasing protein in host defence against gram-negative bacteria and endotoxin.
    Elsbach P.
    Ciba Found Symp; 1994; 186():176-87; discussion 187-9. PubMed ID: 7768151
    [Abstract] [Full Text] [Related]

  • 2. The bactericidal/permeability increasing protein of neutrophils is a potent antibacterial and anti-endotoxin agent in vitro and in vivo.
    Elsbach P, Weiss J, Doerfler M, Shu C, Kohn F, Ammons WS, Kung AH, Meszaros KK, Parent JB.
    Prog Clin Biol Res; 1994; 388():41-51. PubMed ID: 7831373
    [Abstract] [Full Text] [Related]

  • 3. Effect of lipopolysaccharide (LPS) chain length on interactions of bactericidal/permeability-increasing protein and its bioactive 23-kilodalton NH2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coli.
    Capodici C, Chen S, Sidorczyk Z, Elsbach P, Weiss J.
    Infect Immun; 1994 Jan; 62(1):259-65. PubMed ID: 8262637
    [Abstract] [Full Text] [Related]

  • 4. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
    Weiss J, Elsbach P, Shu C, Castillo J, Grinna L, Horwitz A, Theofan G.
    J Clin Invest; 1992 Sep; 90(3):1122-30. PubMed ID: 1522221
    [Abstract] [Full Text] [Related]

  • 5. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide.
    Elsbach P, Weiss J.
    Immunobiology; 1993 Apr; 187(3-5):417-29. PubMed ID: 8330906
    [Abstract] [Full Text] [Related]

  • 6. Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils.
    Ooi CE, Weiss J, Doerfler ME, Elsbach P.
    J Exp Med; 1991 Sep 01; 174(3):649-55. PubMed ID: 1875165
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of neonatal innate defense: effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and tumor necrosis factor-inducing activity of gram-negative bacteria tested in neonatal cord blood ex vivo.
    Levy O, Sisson RB, Kenyon J, Eichenwald E, Macone AB, Goldmann D.
    Infect Immun; 2000 Sep 01; 68(9):5120-5. PubMed ID: 10948134
    [Abstract] [Full Text] [Related]

  • 8. Structural and functional organization of the human neutrophil 60 kDa bactericidal/permeability-increasing protein.
    Ooi CE, Weiss J, Elsbach P.
    Agents Actions; 1991 Sep 01; 34(1-2):274-7. PubMed ID: 1793043
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Therapeutic potential of the bactericidal/permeability-increasing protein.
    Levy O.
    Expert Opin Investig Drugs; 2002 Feb 01; 11(2):159-67. PubMed ID: 11829710
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense.
    Elsbach P.
    J Leukoc Biol; 1998 Jul 01; 64(1):14-8. PubMed ID: 9665269
    [Abstract] [Full Text] [Related]

  • 15. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
    Chockalingam A, McKinney CE, Rinaldi M, Zarlenga DS, Bannerman DD.
    Vet Microbiol; 2007 Nov 15; 125(1-2):80-90. PubMed ID: 17560054
    [Abstract] [Full Text] [Related]

  • 16. [A study on bactericidal/permeability increasing protein (BPI) as a natural inhibitor of endotoxin].
    Zhou H.
    Zhonghua Shao Shang Za Zhi; 2001 Apr 15; 17(2):102-4. PubMed ID: 11876922
    [Abstract] [Full Text] [Related]

  • 17. High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide.
    Gazzano-Santoro H, Parent JB, Grinna L, Horwitz A, Parsons T, Theofan G, Elsbach P, Weiss J, Conlon PJ.
    Infect Immun; 1992 Nov 15; 60(11):4754-61. PubMed ID: 1398985
    [Abstract] [Full Text] [Related]

  • 18. A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion.
    Dahlberg PS, Acton RD, Battafarano RJ, Uknis ME, Ratz CA, Johnston JW, Haseman JR, Gray BH, Dunn DL.
    J Surg Res; 1996 Jun 15; 63(1):44-8. PubMed ID: 8661170
    [Abstract] [Full Text] [Related]

  • 19. The region around residue 115 of human bactericidal/permeability-increasing protein is not involved in lipopolysaccharide binding or bactericidal activity. Chemical synthesis and expression of a gene coding for the active domain and characterization of recombinant proteins.
    Qi SY, Li Y, O'Connor CD.
    Biochem J; 1994 Mar 15; 298 Pt 3(Pt 3):711-8. PubMed ID: 8141787
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.